The Global Intrauterine devices (IUD’S) Market was worth $ 1,400 million in 2016 and estimated to reach $ 1,768 million by the end of 2021 with a growing potential of 4.78 %.
Intrauterine devices are small contraceptive devices, often T-shaped, containing either levonorgestrel or copper, which are injected into the uterus. They are an effective type of reversible birth control and are a form of long-acting contraception. This market is predicted to show the modest growth during the forecast period and is influenced by the different regional trends that segment the market when it comes to the availability of different contraceptive devices.
Upcoming trends such as the growing incidence of unintended pregnancies are quickly gaining popularity as it helps to control gratuitous healthcare expenditure on abortions. Recently, it has been observed that nearly 60% of all pregnancies are unwanted, unintended and are mistimed. Therefore, governments and non-profit organizations across the world are promoting the use of intrauterine devices, along with family planning, birth control measures to stop unplanned pregnancies. Additionally, the arrangement of various awareness programs by organizations like the ESC, APCOC, IPPF, and FIGO are predicted to amplify the sale of IUDs during the forecast period.
Major factors that influence the growth of the market are advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), immediate health benefits other than birth control, Rise in government initiatives to prevent unwanted abortions and pregnancies. Restraints that are hindering the growth of the market are Cultural or religious oppositions prevalent in many countries, Economic constraints, Infertility issues, ectopic pregnancy, pelvic inflammatory infection and Limited access to contraception.
The Global Intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. Hormonal intrauterine devices is estimated to have highest market share in the market. Since hormonal intrauterine devices have less complications and risks compared to non-hormonal intrauterine devices.
Some of the major companies operating in global intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.